메뉴 건너뛰기




Volumn 525, Issue 7569, 2015, Pages E1-E2

Decompensated cirrhosis and microbiome interpretation

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LACTULOSE; PROTON PUMP INHIBITOR; RIFAXIMIN;

EID: 84942022353     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14851     Document Type: Note
Times cited : (93)

References (15)
  • 1
    • 40049097359 scopus 로고    scopus 로고
    • Liver cirrhosis
    • Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838-851 (2008).
    • (2008) Lancet , vol.371 , pp. 838-851
    • Schuppan, D.1    Afdhal, N.H.2
  • 2
    • 84907225684 scopus 로고    scopus 로고
    • Alterationsof the humangut microbiome inliver cirrhosis
    • Qin, N. et al. Alterationsof the humangut microbiome inliver cirrhosis. Nature 513, 59-64 (2014).
    • (2014) Nature , vol.513 , pp. 59-64
    • Qin, N.1
  • 3
    • 83755186465 scopus 로고    scopus 로고
    • Linkage of gut microbiome with cognition in hepatic encephalopathy
    • Bajaj, J. S. et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G168-G175 (2012).
    • (2012) Am. J. Physiol. Gastrointest. Liver Physiol. , vol.302 , pp. G168-G175
    • Bajaj, J.S.1
  • 4
    • 79960714764 scopus 로고    scopus 로고
    • Characterization of fecal microbial communities in patients with liver cirrhosis
    • Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562-572 (2011).
    • (2011) Hepatology , vol.54 , pp. 562-572
    • Chen, Y.1
  • 5
    • 84866396844 scopus 로고    scopus 로고
    • Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
    • Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G675-G685 (2012).
    • (2012) Am. J. Physiol. Gastrointest. Liver Physiol. , vol.303 , pp. G675-G685
    • Bajaj, J.S.1
  • 7
    • 84863429294 scopus 로고    scopus 로고
    • A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy
    • Bajaj, J. S. et al. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab. Brain Dis. 27, 205-215 (2012).
    • (2012) Metab. Brain Dis. , vol.27 , pp. 205-215
    • Bajaj, J.S.1
  • 8
    • 84898830272 scopus 로고    scopus 로고
    • Altered profile of human gut microbiome is associated with cirrhosis and its complications
    • Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940-947 (2014).
    • (2014) J. Hepatol. , vol.60 , pp. 940-947
    • Bajaj, J.S.1
  • 9
    • 84875670330 scopus 로고    scopus 로고
    • Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy
    • Bajaj, J. S. et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE 8, e60042(2013).
    • (2013) PLoS ONE , vol.8
    • Bajaj, J.S.1
  • 10
    • 62649090759 scopus 로고    scopus 로고
    • Gastric acid reduction leads to an alteration in lower intestinal microflora
    • Kanno, T. et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem. Biophys. Res. Commun. 381, 666-670 (2009).
    • (2009) Biochem. Biophys. Res. Commun. , vol.381 , pp. 666-670
    • Kanno, T.1
  • 11
    • 84922392216 scopus 로고    scopus 로고
    • Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function
    • Bajaj, J. S. et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.Am. J. Physiol. Gastrointest. Liver Physiol. 307, G951-G957 (2014).
    • (2014) Am. J. Physiol. Gastrointest. Liver Physiol. , vol.307 , pp. G951-G957
    • Bajaj, J.S.1
  • 12
    • 79959383523 scopus 로고    scopus 로고
    • Metagenomic biomarker discovery and explanation
    • Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).
    • (2011) Genome Biol. , vol.12 , pp. R60
    • Segata, N.1
  • 13
    • 77952771845 scopus 로고    scopus 로고
    • Quantitative assessment of the human gut microbiome using multitag pyrosequencing
    • Gillevet, P., Sikaroodi, M., Keshavarzian, A. & Mutlu, E. A. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem. Biodivers. 7, 1065-1075 (2010).
    • (2010) Chem. Biodivers , vol.7 , pp. 1065-1075
    • Gillevet, P.1    Sikaroodi, M.2    Keshavarzian, A.3    Mutlu, E.A.4
  • 14
    • 84885480599 scopus 로고    scopus 로고
    • Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing
    • Zhang, Z. et al. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am. J. Gastroenterol. 108, 1601-1611 (2013).
    • (2013) Am. J. Gastroenterol. , vol.108 , pp. 1601-1611
    • Zhang, Z.1
  • 15
    • 84906793985 scopus 로고    scopus 로고
    • Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C
    • Elkrief, L. et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 60, 823-831 (2014).
    • (2014) Hepatology , vol.60 , pp. 823-831
    • Elkrief, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.